167 related articles for article (PubMed ID: 8429039)
1. Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9.
Hamilton KK; Zhao J; Sims PJ
J Biol Chem; 1993 Feb; 268(5):3632-8. PubMed ID: 8429039
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
Rosenfeld SI; Packman CH; Leddy JP
J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
[TBL] [Abstract][Full Text] [Related]
3. The terminal complement proteins C5b-9 augment binding of high density lipoprotein and its apolipoproteins A-I and A-II to human endothelial cells.
Hamilton KK; Sims PJ
J Clin Invest; 1991 Dec; 88(6):1833-40. PubMed ID: 1752944
[TBL] [Abstract][Full Text] [Related]
4. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
6. Membrane attack complex proteins C5b-6, C7, C8, and C9 of human complement.
Esser AF; Sodetz JM
Methods Enzymol; 1988; 162():551-78. PubMed ID: 3226325
[No Abstract] [Full Text] [Related]
7. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
8. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
[TBL] [Abstract][Full Text] [Related]
9. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization.
McDonald JF; Nelsestuen GL
Biochemistry; 1997 Jun; 36(24):7464-73. PubMed ID: 9200695
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
Podack ER; Preissner KT; Müller-Eberhard HJ
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
[TBL] [Abstract][Full Text] [Related]
12. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane channel-formation by five complement proteins.
Müller-Eberhard HJ
Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
15. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
[TBL] [Abstract][Full Text] [Related]
16. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
Stewart JL; Monahan JB; Brickner A; Sodetz JM
Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
[TBL] [Abstract][Full Text] [Related]
17. Fluid-phase assembly of the membrane attack complex of complement.
Silversmith RE; Nelsestuen GL
Biochemistry; 1986 Feb; 25(4):841-51. PubMed ID: 3964648
[TBL] [Abstract][Full Text] [Related]
18. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
19. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
Stewart JL; Kolb WP; Sodetz JM
J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
[TBL] [Abstract][Full Text] [Related]
20. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
Kontermann R; Deppisch R; Rauterberg EW
Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]